Abstract:alpha-Synuclein (alphaSyn), an intrinsically disordered protein implicated in Parkinson's disease, is potentially thought to initiate aggregation through binding to cellular membranes. Previous studies have suggested that anionic membrane charge is necessary for this binding. However, these studies largely focus on unmodified alphaSyn, while nearly all alphaSyn in the body is N-terminally acetylated (NTA). Here, we show that NTA drastically changes alphaSyn's membrane binding behavior by reducing its dependence on anionic charge. We found that membrane packing defects, rather than anionic charge, are the primary drivers of NTA-alphaSyn binding. Using fluorescence microscopy and circular dichroism spectroscopy, we monitored the binding of NTA-alphaSyn to reconstituted membrane surfaces with different lipid compositions. Phosphatidylcholine and phosphatidylserine concentrations were varied to control surface charge, while phospholipid tail unsaturation and methylation were varied to control lipid packing. All-atom molecular dynamics simulations of lipid bilayers supported the observation that membrane packing defects are necessary for NTA-alphaSyn binding and that defect-rich membranes are sufficient for NTA-alphaSyn binding regardless of membrane charge. We further demonstrated that this affinity for membrane defects persisted in reconstituted, cholesterol-containing membranes that mimicked the physiological lipid composition of synaptic vesicles. Increasing phospholipid unsaturation in these mimics led to more membrane packing defects and a corresponding increase in NTA-alphaSyn binding. Altogether, our results point to a mechanism for the regulation of NTA-alphaSyn binding in biological membranes that extends beyond phospholipid charge to the structural properties of the lipids themselves.

Chaperone-like activities of alpha-synuclein: alpha-synuclein assists enzyme activities of esterases

Structural changes in α-synuclein affect its chaperone-like activity in vitro

α-Synuclein acts as a cholesteryl-ester sensor on lipid droplets regulating organelle size and abundance.

Thermodynamic Stability Modulates Chaperone-Mediated Disaggregation of α-Synuclein Fibrils

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity

Amyloid Fibers of α-Synuclein Catalyze Chemical Reactions

Synergistic Multi-Pronged Interactions Mediate the Effective Inhibition of Alpha-Synuclein Aggregation by the Chaperone HtrA1

Influence of Cholesterol on the Membrane Binding and Conformation of ?-Synuclein

The Role of Alpha Synuclein in Synucleinopathy: Impact on Lipid Regulation at Mitochondria ER Membranes

β-synuclein regulates the phase transitions and amyloid conversion of α-synuclein

Characterization of the Non-Fibrillar alpha-Synuclein Oligomers

The role of polo-like kinases 2 in the proteasomal and lysosomal degradation of alpha-synuclein in neurons

Elucidating the mechanisms of α-Synuclein-lipid interactions using site-directed mutagenesis

Enzymatic O-GlcNAcylation of Α-Synuclein Reduces Aggregation and Increases SDS-resistant Soluble Oligomers

Lipid Packing Defects are Necessary and Sufficient for Membrane Binding of alpha-Synuclein

Age- and Brain Region-Dependent Α-Synuclein Oligomerization is Attributed to Alterations in Intrinsic Enzymes Regulating Α-Synuclein Phosphorylation in Aging Monkey Brains

Α‐synuclein Stimulation of Monoamine Oxidase‐b and Legumain Protease Mediates the Pathology of Parkinson's Disease

Influence of Cholesterol on the Membrane Binding and Conformation of α-Synuclein

Conformation-specific binding of alpha-synuclein to novel protein partners detected by phage display and NMR spectroscopy.

Effect of Acidic Ph on the Stability of Alpha-Synuclein Dimers

The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends